Interchange Capital Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Interchange Capital Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$242K	Buy	+5,750	New	+$183K	0.05%	358
2026 Q1	–	Sell	-13,558	Closed	-$393K	–	316
2025 Q4	$393K	Buy	13,558 +916	+7%	+$27.5K	0.07%	239
2025 Q3	$351K	Buy	+12,642	New	+$319K	0.07%	237
2021 Q4	–	Sell	-9,560	Closed	-$714K	–	153
2021 Q3	$714K	Buy	9,560 +344	+4%	+$28.9K	1.19%	27
2021 Q2	$852K	Buy	9,216 +834	+10%	+$70.9K	1.32%	25
2021 Q1	$745K	Buy	8,382 +562	+7%	+$55.7K	0.4%	82
2020 Q4	$729K	Buy	+7,820	New	+$623K	0.4%	67

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Interchange Capital Partners's ARKG Position: Q2 2026 in Review

Interchange Capital Partners opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 5,750 shares worth $242K. The stake represents 0.05% of the portfolio and ranks #358 among its holdings. This is a return to the name: Interchange Capital Partners previously reported a position in ARKG as recently as Q4 2025.

Interchange Capital Partners first reported a position in ARKG in Q4 2020 and has held it in 7 quarters since. The position peaked at $852K in Q2 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Interchange Capital Partners held 5,750 shares of ARK Genomic Revolution ETF worth $242K as of Q2 2026.
ARK Genomic Revolution ETF was a new Interchange Capital Partners position in Q2 2026.
ARK Genomic Revolution ETF made up 0.05% of Interchange Capital Partners's portfolio in Q2 2026, its #358 holding.
Interchange Capital Partners first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 7 quarters since.
Interchange Capital Partners's ARK Genomic Revolution ETF position peaked at $852K in Q2 2021.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.